Progression of Cerebellar Atrophy in Spinocerebellar Ataxia Type 2 Gene Carriers: A Longitudinal MRI Study in Preclinical and Early Disease Stages.

cerebellar lobule segmentation cerebellar structural MRI cognitive assessment cortical thickness pre-symptomatic gene carriers spinocerebellar ataxia (SCA2) symbol digit modalities test

Journal

Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899

Informations de publication

Date de publication:
2020
Historique:
received: 13 10 2020
accepted: 17 11 2020
entrez: 1 1 2021
pubmed: 2 1 2021
medline: 2 1 2021
Statut: epublish

Résumé

Spinocerebellar ataxias type 2 (SCA2) is an autosomal dominant inherited disease caused by expanded trinucleotide repeats (≥32 CAG) within the coding region of

Identifiants

pubmed: 33384659
doi: 10.3389/fneur.2020.616419
pmc: PMC7770103
doi:

Types de publication

Journal Article

Langues

eng

Pagination

616419

Informations de copyright

Copyright © 2020 Nigri, Sarro, Mongelli, Pinardi, Porcu, Castaldo, Ferraro, Grisoli, Bruzzone, Gellera, Taroni, Mariotti and Nanetti.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Neurology. 2006 Jun 13;66(11):1717-20
pubmed: 16769946
Cerebellum. 2012 Mar;11(1):272-9
pubmed: 21850525
PLoS One. 2015 Aug 11;10(8):e0135449
pubmed: 26263162
J Neurol. 2013 Dec;260(12):3134-43
pubmed: 24122064
Mov Disord. 2014 May;29(6):780-6
pubmed: 24375449
Front Neurol. 2019 Aug 13;10:832
pubmed: 31456732
J Neurol Sci. 2014 Dec 15;347(1-2):50-8
pubmed: 25263602
J Neurol. 2007 Oct;254(10):1455-6
pubmed: 17680296
Brain. 2013 Mar;136(Pt 3):905-17
pubmed: 23423669
Eur J Neurol. 2005 Sep;12(9):725-8
pubmed: 16128876
Neuroimage. 2016 Nov 1;141:542-555
pubmed: 27426838
Neuroscience. 2017 Dec 16;366:44-53
pubmed: 29031602
Brain Struct Funct. 2011 Sep;216(3):275-88
pubmed: 21461742
Neuroimage. 2017 Feb 15;147:916-924
pubmed: 27833012
J Neuropsychol. 2018 Sep;12(3):471-483
pubmed: 28477351
Orphanet J Rare Dis. 2013 Nov 13;8:177
pubmed: 24225362
Neurology. 2015 Jul 7;85(1):96-103
pubmed: 26062625
Nature. 2017 Apr 20;544(7650):362-366
pubmed: 28405024
J Med Genet. 2014 Jul;51(7):479-86
pubmed: 24780882
Parkinsonism Relat Disord. 2011 Aug;17(7):521-7
pubmed: 21600833
Lancet Neurol. 2015 Nov;14(11):1101-8
pubmed: 26377379
Arch Clin Neuropsychol. 2006 Jan;21(1):23-8
pubmed: 16139470
Neuroimage Clin. 2018 Jun 14;19:858-867
pubmed: 29922574
Lancet Neurol. 2013 Jul;12(7):650-8
pubmed: 23707147
Lancet Neurol. 2014 May;13(5):482-9
pubmed: 24657153
Ann Neurol. 2018 Sep;84(3):401-408
pubmed: 30014526
Eur J Hum Genet. 2010 Nov;18(11):1188-95
pubmed: 20179748
Cerebellum. 2015 Apr;14(2):175-96
pubmed: 25382714
Mov Disord. 2011 Sep;26(11):2081-7
pubmed: 21626567
Lancet Neurol. 2013 Jul;12(7):637-49
pubmed: 23664844
Nat Rev Dis Primers. 2019 Apr 11;5(1):24
pubmed: 30975995
J Neurol. 2018 Dec;265(12):2949-2959
pubmed: 30324307
Lancet Neurol. 2020 Sep;19(9):738-747
pubmed: 32822634
Int J Mol Sci. 2020 Feb 04;21(3):
pubmed: 32033120
Mov Disord. 2004 Jun;19(6):622-9
pubmed: 15197699
J Neurol. 2020 Apr 7;:
pubmed: 32266540
Ann Clin Transl Neurol. 2018 Jan 07;5(2):128-137
pubmed: 29468174
AJNR Am J Neuroradiol. 2015 Jun;36(6):1096-101
pubmed: 25882284
Cerebellum. 2013 Jun;12(3):418-28
pubmed: 23090211
Arch Neurol. 2012 Apr;69(4):500-8
pubmed: 22491195
Mov Disord. 2017 May;32(5):708-718
pubmed: 28256108
Neuroreport. 2003 Oct 6;14(14):1799-802
pubmed: 14534423
Cerebellum. 2014 Oct;13(5):568-79
pubmed: 24906824
Neurology. 2011 Sep 13;77(11):1035-41
pubmed: 21832228
Neuroimage. 2015 Jun;113:184-95
pubmed: 25776214
PLoS One. 2014 Feb 25;9(2):e89410
pubmed: 24586758
Mov Disord. 2008 Apr 30;23(6):899-903
pubmed: 18311829
Orphanet J Rare Dis. 2018 Jan 25;13(1):20
pubmed: 29370806
Neuroimage. 2004 Oct;23(2):724-38
pubmed: 15488422
Brain. 2004 Aug;127(Pt 8):1785-95
pubmed: 15240431
Neuroepidemiology. 2014;42(3):174-83
pubmed: 24603320
Neuron. 2002 Jan 31;33(3):341-55
pubmed: 11832223

Auteurs

Anna Nigri (A)

Department of Neuroradiology, Fondazione Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Istituto Neurologico Carlo Besta, Milan, Italy.

Lidia Sarro (L)

Department of Medical Genetics and Neurogenetics, Fondazione Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Istituto Neurologico Carlo Besta, Milan, Italy.
Ospedale Martini, Turin, Italy.

Alessia Mongelli (A)

Department of Medical Genetics and Neurogenetics, Fondazione Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Istituto Neurologico Carlo Besta, Milan, Italy.

Chiara Pinardi (C)

Department of Neuroradiology, Fondazione Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Istituto Neurologico Carlo Besta, Milan, Italy.

Luca Porcu (L)

Laboratory of Methodology for Clinical Research, Oncology Department, Istituto di Ricerche Farmacologiche Mario Negri Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), Milan, Italy.

Anna Castaldo (A)

Department of Medical Genetics and Neurogenetics, Fondazione Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Istituto Neurologico Carlo Besta, Milan, Italy.

Stefania Ferraro (S)

Department of Neuroradiology, Fondazione Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Istituto Neurologico Carlo Besta, Milan, Italy.

Marina Grisoli (M)

Department of Neuroradiology, Fondazione Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Istituto Neurologico Carlo Besta, Milan, Italy.

Maria Grazia Bruzzone (MG)

Department of Neuroradiology, Fondazione Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Istituto Neurologico Carlo Besta, Milan, Italy.

Cinzia Gellera (C)

Department of Medical Genetics and Neurogenetics, Fondazione Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Istituto Neurologico Carlo Besta, Milan, Italy.

Franco Taroni (F)

Department of Medical Genetics and Neurogenetics, Fondazione Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Istituto Neurologico Carlo Besta, Milan, Italy.

Caterina Mariotti (C)

Department of Medical Genetics and Neurogenetics, Fondazione Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Istituto Neurologico Carlo Besta, Milan, Italy.

Lorenzo Nanetti (L)

Department of Medical Genetics and Neurogenetics, Fondazione Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Istituto Neurologico Carlo Besta, Milan, Italy.

Classifications MeSH